Swiss National Bank
HAE icon

Swiss National Bank’s Haemonetics HAE Stock Holding History

Swiss National Bank’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7M Buy
93,300
+700
+0.8% +$45K ﹤0.01% 1248
2026
Q1 		$5.22M Sell
92,600
-2,400
-3% -$156K ﹤0.01% 1346
2025
Q4 		$7.61M Buy
95,000
+1,900
+2% +$128K ﹤0.01% 1115
2025
Q3 		$4.54M Sell
93,100
-2,800
-3% -$173K ﹤0.01% 1386
2025
Q2 		$7.16M Sell
95,900
-1,400
-1% -$92.7K ﹤0.01% 1091
2025
Q1 		$6.18M Sell
97,300
-3,400
-3% -$231K ﹤0.01% 1131
2024
Q4 		$7.86M Buy
100,700
+1,200
+1% +$96.4K 0.01% 1062
2024
Q3 		$8M Sell
99,500
-400
-0.4% -$32.3K 0.01% 1054
2024
Q2 		$8.26M Hold
99,900
– – 0.01% 985
2024
Q1 		$8.53M Hold
99,900
– – 0.01% 995
2023
Q4 		$8.54M Sell
99,900
-11,300
-10% -$977K 0.01% 983
2023
Q3 		$9.96M Buy
111,200
+1,400
+1% +$125K 0.01% 887
2023
Q2 		$9.35M Buy
109,800
+600
+0.5% +$50.7K 0.01% 947
2023
Q1 		$9.04M Sell
109,200
-14,800
-12% -$1.2M 0.01% 934
2022
Q4 		$9.75M Buy
124,000
+2,400
+2% +$193K 0.01% 931
2022
Q3 		$9M Buy
121,600
+800
+0.7% +$57.4K 0.01% 942
2022
Q2 		$7.87M Hold
120,800
– – 0.01% 1045
2022
Q1 		$7.64M Buy
120,800
+8,500
+8% +$462K ﹤0.01% 1184
2021
Q4 		$5.96M Hold
112,300
– – ﹤0.01% 1341
2021
Q3 		$7.93M Buy
112,300
+300
+0.3% +$18.9K 0.01% 1130
2021
Q2 		$7.46M Sell
112,000
-4,100
-4% -$290K ﹤0.01% 1204
2021
Q1 		$12.9M Buy
116,100
+1,500
+1% +$186K 0.01% 861
2020
Q4 		$13.6M Buy
114,600
+400
+0.4% +$43.1K 0.01% 784
2020
Q3 		$9.96M Buy
114,200
+1,900
+2% +$166K 0.01% 802
2020
Q2 		$10.1M Buy
112,300
+14,000
+14% +$1.41M 0.01% 763
2020
Q1 		$9.8M Buy
98,300
+1,100
+1% +$119K 0.01% 676
2019
Q4 		$11.2M Buy
97,200
+800
+0.8% +$96.8K 0.01% 729
2019
Q3 		$12.2M Buy
96,400
+1,500
+2% +$190K 0.01% 702
2019
Q2 		$11.4M Buy
94,900
+700
+0.7% +$68.9K 0.01% 725
2019
Q1 		$8.24M Buy
94,200
+2,800
+3% +$255K 0.01% 820
2018
Q4 		$9.14M Buy
91,400
+300
+0.3% +$31.5K 0.01% 714
2018
Q3 		$10.4M Sell
91,100
-2,000
-2% -$207K 0.01% 722
2018
Q2 		$8.35M Buy
93,100
+1,500
+2% +$127K 0.01% 801
2018
Q1 		$6.7M Buy
91,600
+2,000
+2% +$137K 0.01% 880
2017
Q4 		$5.2M Buy
89,600
+2,100
+2% +$111K 0.01% 1032
2017
Q3 		$3.93M Hold
87,500
– – ﹤0.01% 1173
2017
Q2 		$3.46M Buy
87,500
+2,000
+2% +$82.1K ﹤0.01% 1234
2017
Q1 		$3.47M Buy
85,500
+1,200
+1% +$46.9K ﹤0.01% 1226
2016
Q4 		$3.39M Buy
84,300
+3,000
+4% +$113K 0.01% 1218
2016
Q3 		$2.94M Sell
81,300
-2,900
-3% -$99.6K ﹤0.01% 1255
2016
Q2 		$2.44M Buy
84,200
+700
+0.8% +$21.2K ﹤0.01% 1358
2016
Q1 		$2.82M Buy
83,500
+15,300
+22% +$494K 0.01% 1216
2015
Q4 		$2.2M Hold
68,200
– – 0.01% 1275
2015
Q3 		$2.2M Buy
68,200
+8,800
+15% +$331K 0.01% 1230
2015
Q2 		$2.46M Buy
59,400
+700
+1% +$29.5K 0.01% 1181
2015
Q1 		$2.64M Buy
58,700
+1,000
+2% +$41.8K 0.01% 1115
2014
Q4 		$2.16M Buy
57,700
+700
+1% +$25.6K 0.01% 1206
2014
Q3 		$1.99M Sell
57,000
-800
-1% -$28.5K 0.01% 1195
2014
Q2 		$2.04M Hold
57,800
– – 0.01% 1244
2014
Q1 		$1.88M Buy
57,800
+12,800
+28% +$489K 0.01% 1251
2013
Q4 		$1.9M Buy
45,000
+500
+1% +$20.6K 0.01% 1089
2013
Q3 		$1.77M Sell
44,500
-2,800
-6% -$117K 0.01% 1081
2013
Q2 		$1.96M Buy
+47,300
New +$1.91M 0.01% 998

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Swiss National Bank's HAE Position: Q2 2026 in Review

Swiss National Bank increased its Haemonetics (HAE) stake by 0.76% in Q2 2026, buying an estimated $45K and bringing the position to 93,300 shares worth $7M. The position accounts for ﹤0.01% of the portfolio, ranked #1248.

Swiss National Bank first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.6M in Q4 2020. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Swiss National Bank held 93,300 shares of Haemonetics worth $7M as of Q2 2026.
  • Swiss National Bank bought 700 Haemonetics shares in Q2 2026, an estimated $45K.
  • Haemonetics made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1248 holding.
  • Swiss National Bank first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
  • Swiss National Bank's Haemonetics position peaked at $13.6M in Q4 2020.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.